Nymox Pharmaceutical
NYMX
#10189
Rank
S$23.65 M
Marketcap
Country
S$0.26
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Nymox Pharmaceutical (NYMX) - Net assets

Net assets on the balance sheet as of June 2023 : -S$3.73 Million

According to Nymox Pharmaceutical's latest financial reports the company has -S$3.73 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Nymox Pharmaceutical - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2022-12-31$-S$0.65 Million-5.54%
2021-12-31$-S$0.69 Million-124.11%
2020-12-31$S$2.83 M-38.95%
2019-12-31$S$4.64 M-51.4%
2018-12-31$S$9.56 M-671.7%
2017-12-31$-S$1.68 Million80.24%
2016-12-31$-S$0.93 Million-76.16%
2015-12-31$-S$3.9 Million-29.51%
2014-12-31$-S$5.53 Million-28.03%
2013-12-31$-S$7.68 Million-15.69%
2012-12-31$-S$9.11 Million35.25%
2011-12-31$-S$6.74 Million83.06%
2010-12-31$-S$3.68 Million80.36%
2009-12-31$-S$2.04 Million-150.72%
2008-12-31$S$4.01 M-5.81%
2007-12-31$S$4.26 M52.37%
2006-12-31$S$2.8 M38.78%
2005-12-31$S$2.01 M-38.53%
2004-12-31$S$3.28 M-19.43%
2003-12-31$S$4.07 M-18.65%
2002-12-31$S$5 M-21.45%
2001-12-31$S$6.37 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Abbott Laboratories
ABT
S$66.43 B-1,781,956.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$120.64 B-3,235,970.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$9.55 B-256,478.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$30.90 B-829,116.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$102.73 B-2,755,643.97%๐Ÿ‡บ๐Ÿ‡ธ USA